Clinical Trial Update: A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and tolerability of single and multiple doses of AZD4831 in healthy male subjects; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• AZD4831 (AZD4831)

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Disease | Phase 1 | Status: TERMINATED